Lilly antibody drug fails in a COVID 19 study; others go on

almost 5 years in Independent

U.S. government officials are putting an early end to a study testing an Eli Lilly antibody drug for people hospitalized with COVID-19 because it doesn’t seem to help

Mentioned in this news
Share it on